These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10910040)

  • 1. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of p63 protein in human esophageal squamous cell carcinomas.
    Hu H; Xia SH; Li AD; Xu X; Cai Y; Han YL; Wei F; Chen BS; Huang XP; Han YS; Zhang JW; Zhang X; Wu M; Wang MR
    Int J Cancer; 2002 Dec; 102(6):580-3. PubMed ID: 12447998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
    Chen YK; Hsue SS; Lin LM
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
    Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
    Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p63 expression is associated with tumor progression in bladder cancer.
    Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
    Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 gene expression study and early bladder carcinogenesis.
    Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
    King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
    Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
    Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
    Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
    Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
    Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of limbal keratinocyte proliferation and differentiation by TAp63 and DeltaNp63 transcription factors.
    Wang DY; Cheng CC; Kao MH; Hsueh YJ; Ma DH; Chen JK
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3102-8. PubMed ID: 16123408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
    Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
    Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
    Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression.
    Preto A; Reis-Filho JS; Ricardo S; Soares P
    Pathol Res Pract; 2002; 198(7):449-54. PubMed ID: 12234063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.